一项个性化临床决策支持干预措施改善动脉粥样硬化性心血管疾病患者他汀类药物处方的整群随机试验。 - Suppr

Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease.

作者信息

Virani Salim S, Ramsey David J, Westerman Dax, Kuebeler Mark K, Chen Liang, Akeroyd Julia M, Gobbel Glenn T, Ballantyne Christie M, Petersen Laura A, Turchin Alexander, Matheny Michael E

机构信息

Health Policy, Quality & Informatics Program, Michael E. DeBakey Veterans Affairs Medical Center, Health Services Research & Development Center for Innovations in Quality, Effectiveness, and Safety, Houston, TX (S.S.V., D.J.R., M.K.K., J.M.A., L.A.P.).

Section of Cardiovascular Research (S.S.V., C.M.B.), Department of Medicine, Baylor College of Medicine, Houston, TX.

出版信息

Circulation. 2023 May 2;147(18):1411-1413. doi: 10.1161/CIRCULATIONAHA.123.064226. Epub 2023 Mar 5.

DOI:10.1161/CIRCULATIONAHA.123.064226

PMID:36871214

Abstract

摘要

相似文献

Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease.

Circulation. 2023 May 2;147(18):1411-1413. doi: 10.1161/CIRCULATIONAHA.123.064226. Epub 2023 Mar 5.

Effect of Passive Choice and Active Choice Interventions in the Electronic Health Record to Cardiologists on Statin Prescribing: A Cluster Randomized Clinical Trial.

JAMA Cardiol. 2021 Jan 1;6(1):40-48. doi: 10.1001/jamacardio.2020.4730.

Editorial commentary: Statin for primary prevention of atherosclerotic cardiovascular disease in young adults: Are we there yet?

Trends Cardiovasc Med. 2020 Jan;30(1):54-55. doi: 10.1016/j.tcm.2019.02.010. Epub 2019 Mar 5.

Effectiveness of Interventions Aimed at Increasing Statin-Prescribing Rates in Primary Cardiovascular Disease Prevention: A Systematic Review of Randomized Clinical Trials.

JAMA Cardiol. 2019 Nov 1;4(11):1160-1169. doi: 10.1001/jamacardio.2019.3066.

Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance: Randomized Feasibility Trial.

JACC Cardiovasc Imaging. 2022 May;15(5):843-855. doi: 10.1016/j.jcmg.2021.11.006. Epub 2021 Dec 15.

Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System.

J Am Heart Assoc. 2019 Nov 19;8(22):e014709. doi: 10.1161/JAHA.119.014709. Epub 2019 Nov 11.

Statins for Primary Prevention of Cardiovascular Disease: Review of Evidence and Recommendations for Clinical Practice.

Med Clin North Am. 2017 Jul;101(4):689-699. doi: 10.1016/j.mcna.2017.03.001.

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States.

J Am Heart Assoc. 2023 Apr 18;12(8):e029263. doi: 10.1161/JAHA.122.029263. Epub 2023 Apr 7.

Atherosclerotic cardiovascular disease risk assessment and predictors of statin use in Filipino-American Women.

J Clin Pharm Ther. 2019 Aug;44(4):632-639. doi: 10.1111/jcpt.12837. Epub 2019 Apr 8.

A randomized trial assessing the impact of a personal printed feedback portrait on statin prescribing in primary care.

J Contin Educ Health Prof. 2012 Summer;32(3):153-62. doi: 10.1002/chp.21140.

引用本文的文献

Novel Interventions to Improve Adherence to Guideline-Directed Medical Therapy in Claudicants.

J Clin Med. 2025 Jul 28;14(15):5309. doi: 10.3390/jcm14155309.

A qualitative study of a new metric for estimating early-onset colorectal cancer risk in male veterans: "Colon Age".

BMC Prim Care. 2025 Jul 15;26(1):226. doi: 10.1186/s12875-025-02854-6.

Implementing a Cardiology Quality Incentive Program to Improve Guideline-Directed Medical Therapy.

JACC Adv. 2025 Jun 20;4(7):101879. doi: 10.1016/j.jacadv.2025.101879.

Strategies to Improve Health Care Provider Prescription of and Patient Adherence to Guideline-Recommended Cardiovascular Medications for Atherosclerotic Occlusive Disease: Protocol for Two Systematic Reviews and Meta-Analyses of Randomized Controlled Trials.

JMIR Res Protoc. 2025 Jan 16;14:e60326. doi: 10.2196/60326.

Closing the Gaps in Care of Dyslipidemia: Revolutionizing Management with Digital Health and Innovative Care Models.

Rev Cardiovasc Med. 2023 Dec 13;24(12):350. doi: 10.31083/j.rcm2412350. eCollection 2023 Dec.

World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update.

Glob Heart. 2024 Jan 22;19(1):8. doi: 10.5334/gh.1278. eCollection 2024.

Cardioprotective and Antifibrotic Effects of Low-Dose Renin-Angiotensin-Aldosterone System Inhibitors in Type 1 Diabetic Rat Model.

Int J Mol Sci. 2023 Dec 1;24(23):17043. doi: 10.3390/ijms242317043.

Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum.

J Am Heart Assoc. 2023 Jun 6;12(11):e028892. doi: 10.1161/JAHA.122.028892. Epub 2023 Jun 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease.

作者信息

机构信息

出版信息

相似文献

引用本文的文献